Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D02ZZG
|
|||
| Drug Name |
LEO 43204
|
|||
| Synonyms |
ingenol disoxate; Ingenol disoxate; UNII-3B100VJ4ZW; 3B100VJ4ZW; 1383547-60-1; Ingenol disoxate [INN]; Ingenol disoxate [USAN:INN]; SCHEMBL16153426; CHEMBL3989918; LEO43204; 4-Isoxazolecarboxylic acid, 3,5-diethyl-, (1aR,2S,5R,5aS,6S,8aS,9R,10aR)-1a,2,5,5a,6,9,10,10a-octahydro-5,5a-dihydroxy-4-(hydroxymethyl)-1,1,7,9-tetramethyl-11-oxo-1H-2,8a-methanocyclopenta(a)cyclopropa(E)cyclodecen-6-yl ester
Click to Show/Hide
|
|||
| Indication | Squamous cell carcinoma [ICD-11: 2B60-2D01; ICD-10: C44; ICD-9: 199] | Phase 3 | [1] | |
| Acne vulgaris [ICD-11: ED80; ICD-10: L70.0; ICD-9: 706.1] | Phase 2 | [2] | ||
| Actinic keratosis [ICD-11: EK90.0; ICD-10: L57.0; ICD-9: 702] | Phase 2 | [2] | ||
| Company |
LEO Pharma Madison, NJ
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C28H37NO7
|
|||
| Canonical SMILES |
CCC1=C(C(=NO1)CC)C(=O)OC2C(=CC34C2(C(C(=CC(C3=O)C5C(C5(C)C)CC4C)CO)O)O)C
|
|||
| InChI |
1S/C28H37NO7/c1-7-18-20(19(8-2)36-29-18)25(33)35-24-13(3)11-27-14(4)9-17-21(26(17,5)6)16(23(27)32)10-15(12-30)22(31)28(24,27)34/h10-11,14,16-17,21-22,24,30-31,34H,7-9,12H2,1-6H3/t14-,16+,17-,21+,22-,24+,27+,28+/m1/s1
|
|||
| InChIKey |
GLIUZQUNUNICGS-XUBYYPQFSA-N
|
|||
| CAS Number |
CAS 1383547-60-1
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
| REF 2 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.